Well, the Sox last few dips into high-priced starting pitching involved signing Price, Sale and Eovaldi to a combined total of 16 seasons and committed approval $430mill to those three. With Sale now on the 60 day Injured List, it is safe to say that through the first 15 of those 16 seasons, only three times did a pitcher reach the incredibly low total of 110 IP. (Price in 2016 and 2018, Eovaldi in 2021).
Wacha and Hill each topped that IP total last year for only $12mill. If you want to argue the short term deals are not working, ok. But how did all the long term ones work out any better? And which was has left non-contributing players still on the payroll hamstringing the team from future moves? I’m pretty sure Rich Hill isn’t on the books for $29mill next year…